---
id: quantitative-adverse-outcome-pathways-data
title: Quantitative AOP Data Requirements and Resources
description: Canonical page for data requirements, sources, and management in quantitative adverse outcome pathway development
slug: /datasets/quantitative-adverse-outcome-pathways-data
sidebar_label: qAOP Data
page_type: dataset
entity_class: dataset
status: draft
last_reviewed: 2026-08-08
verification_status: unverified
aliases:
  - qAOP data
  - Quantitative AOP data
  - qAOP datasets
  - Quantitative AOP datasets
---

## Overview

Quantitative Adverse Outcome Pathway (qAOP) development requires comprehensive, high-quality data to characterize key event relationships with quantitative precision. This page covers the data requirements, sources, and management approaches for qAOP development.

## Scope and Notes

This page covers:
- Core data requirements for qAOP development
- Types of data needed for different qAOP modeling approaches
- Key data sources and resources for qAOP development
- Data management and integration challenges
- Quality standards and validation approaches

qAOP data requirements should not be confused with traditional toxicology data needs. The quantitative nature of qAOPs demands more rigorous data standards and comprehensive coverage of key event relationships.

## Data Requirements

### Core Data Types

```yaml
claim_id: clm-qao-data-001
page_id: quantitative-adverse-outcome-pathways-data
claim_type: requirement
statement: qAOP development requires comprehensive data for formulation, parameterization, and testing of key event relationships.
subject: qAOP development
predicate: requires
object: comprehensive data
qualifiers:
  data_types: formulation, parameterization, testing
citations:
  - cit-ecetoc-wr-38
verification_status: unverified
confidence: high
depends_on: []
```

### Formulation Data

Data needed to establish the basic structure of qAOPs:

- **Molecular initiating event data**: Chemical-biological interaction information
- **Key event identification**: Biological processes and endpoints
- **Pathway mapping**: Connections between events
- **Adverse outcome characterization**: Observable health effects

### Parameterization Data

Data needed to quantify relationships between events:

- **Dose-response relationships**: Quantitative characterization of exposure-response
- **Time-course data**: Temporal dynamics of biological effects
- **Species-specific data**: Differences in biological responses across species
- **Population variability**: Individual differences in responses

### Testing Data

Data needed to validate and refine qAOP models:

- **Independent validation datasets**: Data not used in model development
- **Sensitivity analysis data**: Information for parameter importance assessment
- **Uncertainty characterization**: Data for model uncertainty quantification
- **Extrapolation validation**: Data for testing model predictions beyond training ranges

## Key Data Sources

### Public Databases

- **AOP-Wiki**: Comprehensive database of adverse outcome pathways
- **OECD AOP Development Program**: Standardized AOP information
- **US EPA CompTox Chemicals Dashboard**: Chemical toxicity and pathway data
- **ECHA Information Systems**: Regulatory toxicity data
- **EFSA Data Warehouse**: Food safety-related toxicity data

### High-Throughput Screening Data

- **Tox21 program**: High-throughput screening data for toxicity pathways
- **ToxCast**: Chemical screening data for biological activity
- **ToxPrint**: Chemical fingerprinting for pathway analysis
- **OECD QSAR Toolbox**: Chemical property and pathway data

### Omics Data

- **Genomics data**: Gene expression and mutation information
- **Transcriptomics data**: RNA expression profiles
- **Proteomics data**: Protein expression and modification data
- **Metabolomics data**: Metabolic pathway information
- **Epigenomics data**: DNA methylation and chromatin modification data

### Physiologically-Based Data

- **PBTK model parameters**: Physiological and biochemical parameters
- **IVIVE data**: In vitro to in vivo extrapolation information
- **ADME data**: Absorption, distribution, metabolism, and excretion data
- **Toxicokinetic data**: Chemical fate and transport information

## Data Quality Standards

### Core Quality Criteria

- **Completeness**: Comprehensive coverage of key events and relationships
- **Consistency**: Internal coherence and external compatibility
- **Accuracy**: Correctness and reliability of measurements
- **Precision**: Reproducibility and repeatability of data
- **Timeliness**: Relevance and currency of information

### Validation Approaches

- **Cross-validation**: Testing model performance with independent datasets
- **Sensitivity analysis**: Assessing parameter importance and model robustness
- **Uncertainty quantification**: Characterizing model uncertainty and variability
- **Benchmarking**: Comparing model performance against established standards

## Data Management Challenges

### Integration Issues

- **Data heterogeneity**: Differences in data formats and standards
- **Data silos**: Isolation of data in different systems and organizations
- **Data interoperability**: Compatibility issues across platforms
- **Data provenance**: Tracking data sources and transformations

### Quality Assurance

- **Data cleaning**: Removing errors and inconsistencies
- **Data normalization**: Standardizing data formats and scales
- **Data enrichment**: Adding missing information and context
- **Data documentation**: Comprehensive metadata and provenance tracking

### Ethical and Legal Considerations

- **Data privacy**: Protecting sensitive information
- **Data ownership**: Intellectual property and usage rights
- **Data sharing**: Balancing openness with confidentiality
- **Data security**: Protecting data integrity and accessibility

## Future Directions

- Development of standardized data formats and ontologies for qAOP data
- Integration of qAOP data with emerging technologies (e.g., AI, machine learning)
- Improved methods for data sharing and collaboration across organizations
- Enhanced approaches for data quality assurance and validation
- Development of user-friendly data management tools for qAOP development
- Application of qAOP data to complex mixtures and environmental exposures

## Related Pages

- [Quantitative Adverse Outcome Pathways](@{REF}:/concepts/quantitative-adverse-outcome-pathways)
- [Quantitative AOP Modeling Methods](@{REF}:/models-and-methods/quantitative-adverse-outcome-pathways-modeling)
- [Adverse Outcome Pathway Framework](@{REF}:/concepts/aop-framework)
- [High-Throughput Screening](@{REF}:/assays/hts.md)
- [Omics Data in Toxicology](@{REF}:/datasets/omics-data.md)

## Open Questions or Review Notes

- Standardization of data formats and quality criteria for qAOP development
- Development of clear guidelines for data sharing and collaboration
- Integration of qAOP data with regulatory decision-making processes
- Addressing computational challenges in large-scale data integration
- Development of methods for handling missing or uncertain data in qAOP development

## References

```yaml
citation_id: cit-ecetoc-wr-38
source_type: workshop_report
title: Exploring best practices in building qAOPs
authors:
  - European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC)
year: 2023
container: ECETOC Workshop Report No. 38
doi: N/A
url: https://ecetoc.org/publications/workshop-reports/
access_status: accessible
allowed_source: true
retrieved_on: 2026-08-08
pages_or_sections: null
notes: Workshop report focusing on quantitative AOP development and implementation
```